Urogenitalsystem og kjønnshormoner Genito urinary system and sex hormones
|
|
|
- Bennett McGee
- 6 years ago
- Views:
Transcription
1 Urogenitalsystem og kjønnshormoner Genito urinary system and sex hormones G01 G02 G03 G04 Antiinfektiva og antiseptika til gynekologisk bruk Gynecological antiinfectives and antiseptics Andre gynekologiske midler Other gynecologicals Kjønnshormoner og midler med effekt på genitalia Sex hormones and modulators of the genital system Urologika Urologicals Salg pr ATC 3. nivå for gruppe G - Urogenitalsystem og kjønnshormoner Sales per ATC 3rd level for ATC group G - Genito urinary system and sex hormones mill NOK (AUP) G01A Antiinfectives and antiseptics, excl. combinations with corticosteroids 40,0 42,6 41,8 41,2 40,2 G02A Uterotonika 0,2 0,2 0,3 1,6 2,1 G02B Contraceptives for topical use 60,1 59,9 66,5 71,4 79,8 G02C Other gynecologicals 7,4 7,0 7,2 6,2 6,4 G03A Hormonal contraceptives for systemic use 199,1 205,6 211,8 215,3 213,3 G03B Androgens 23,0 27,8 33,0 43,2 56,7 G03C Estrogens 88,5 92,8 97,6 111,6 122,1 G03D Progestogens 15,5 16,4 18,2 18,7 19,1 G03F Progestogens and estrogens in combination 31,2 30,7 34,2 34,8 35,8 G03G Gonadotropins and other ovulation stimulants 71,3 69,8 65,4 73,8 79,8 G03H Antiandrogens 7,4 7,0 6,6 6,5 6,4 G03X Other sex hormones and modulators of the genital system 5,5 4,2 3,8 7,5 11,0 G04B Urologicals 332,2 348,1 353,0 369,0 392,7 G04C Drugs used in benign prostatic hypertrophy 66,7 70,2 71,4 77,2 92,0 Legemiddelstatistikk 2017:1 Folkehelseinstituttet 45
2 G01 Antiinfektiva og antiseptika til gynekologisk bruk 0,98 1,03 1,00 0,95 0,89 G01A Antiinfektiva og antiseptika, ekskl. kombinasjoner med kortikosteroider 0,98 1,03 1,00 0,95 0,89 G01AA10 Klindamycin (0,1 g) 0,06 0,06 0,06 0,06 0,06 G01AC05 Dekvalon (20 mg) 0,00 G01AF01 Metronidazol (0,5 g) 1) 0,03 0,03 0,03 0,03 0,03 G01AF02 Klotrimazol (0,1 g) 0,82 0,88 0,85 0,82 0,76 G01AF05 Ekonazol (0,1 g) 0,07 0,07 0,06 0,05 0,04 G02 Andre gynekologiske midler G02A Uterotonika 2) 0,01 0,01 0,01 0,01 0,01 G02AB Sekalealkaloider 0,00 0,00 0,00 0,00 0,00 G02AD Prostaglandiner 0,01 0,01 0,01 0,01 0,01 number of IUDs or numbers of vaginal rings G02B Antikonseptiva, lokale 3) G02BA03 Plastspiraler med levonorgestrel G02BB01 Vaginal ring med etonorgestrel og etinyløstradiol 4) G02C Andre gynekologiske preparater 0,14 0,14 0,13 0,13 0,12 G02CB Prolaktinhemmende midler 0,14 0,14 0,13 0,13 0,12 G03 Kjønnshormoner og midler med effekt på genitalia G03A Antikonseptiva, hormoner, systemiske G03AA Progestogener og østrogener, faste kombinasjoner G03AB Progestogener og østrogener, sekvensprep G03AC Progestogener 5) G03AC Progestogener, orale G03AC Progestogener, inj G03AC Progestogener, implantat 6) G03AD Nødprevensjon ) Se også ATC gr. P01AB og J01XD. See also ATC group P01AB and J01XD. 2) Omfatter også salg av preparater uten markedsføringstillatelse i Norge. 3) Salg av spiraler uten legemiddel er ikke tatt med. 4) The vaginal ring should be replaced every 28 day. This implies that each user needs 13 vaginal rings per year. 5) Ekskl. salg av implantater. Excluding sales of implants. 6) Salg angitt i antall implantater. Sales given in number of implants. 46 Legemiddelstatistikk 2017:1 Folkehelseinstituttet
3 Salg av P-piller, prevensjonsplaster og nødprevensjon (G03A) Sales of oral and transdermal hormonal contraceptives (G03A) Total (G03A) Komb. preparater (G03AA) Minipiller og nødprevensjon (G03AC, ekskl. inj. og implantat + G03AD) Sekvenspreparater (G03AB) G03B Androgener G03BA03 Testosteron (18 mg P/0,12 g O/50 mg TD gel) G03C Østrogener G03CA03 Østradiol (50 mcg TD/2 mg O/25 mcg V/ 7,5 mcg vaginal ring) G03CA04 Østriol (2 mg O/0,2 mg V) G03CX01 Tibolon (2,5 mg) G03D Progestogener G03DA02 Medroksyprogesteron (5 mg O/7 mg P) G03DA04 Progesteron (90 mg) 1) G03DB08 Dienogest (2 mg) G03DC02 Noretisteron (5 mg) G03F Progestogener og østrogener i kombinasjon G03FA01 Noretisteron og østrogen, komb G03FA12 Medroksyprogesteron og østrogen G03FB05 Noretisteron og østrogen, sekvensprep ) Inkluderer også salg av preparater uten markedsføringstillatelse i Norge. Legemiddelstatistikk 2017:1 Folkehelseinstituttet 47
4 Salg av østrogenholdige preparater (G03C og G03F) Sales of products with estrogen (G03C and G03F) Systemisk behandling inkl. komb. med progestogener (G03CA01+G03CA03+ G03CA04+G03CX01+G03F) Lokal behandling (G03CA03+G03CA04+ G03CB) G03G Gonadotropiner og andre ovulasjonsstimulerende midler 1) G03GA01 Koriongonadotropin (250 U) G03GA02 Menopausegonadotropin (75 U) G03GA04 Urofollitropin (75 U) G03GA05 Follitropin alfa (75 U) G03GA06 Follitropin beta (75 U) G03GA08 Koriongonadotropin alfa (0,25 mg) G03GB02 Klomifen (9 mg) G03H Antiandrogener G03HA01 Cyproteron (0,1 g) G03HB01 Cyproteron og østrogen G03X Andre kjønnshormoner og midler med effekt på genitalia G03XB01 Mifepriston (0,2 g) G03XB02 Ulipristal (5 mg) G03XC01 Raloxifen (60 mg) ) ATC code G03GA07, G03GA09 and G03GA30 are not included due to low sales. 48 Legemiddelstatistikk 2017:1 Folkehelseinstituttet
5 G04 Urologika 20,96 22,02 23,14 23,94 25,60 G04B Urologika 10,82 11,12 11,70 12,12 12,54 G04BD Midler mot hyppig vannlatning og inkontinens 8,84 8,98 9,40 9,61 9,84 G04BD04 Oksybutynin (3,9 mg TD) 0,10 0,08 0,07 0,06 0,06 G04BD07 Tolterodin (4 mg) 1) 1,76 1,49 1,40 1,16 1,06 G04BD08 Solifenacin (5 mg) 4,04 3,87 3,57 3,35 3,27 G04BD10 Darifenacin (7,5 mg) 0,83 0,72 0,59 0,53 0,43 G04BD11 Fesoterodin (4 mg) 2,11 2,35 2,13 1,98 1,88 G04BD12 Mirabegron (50 mg) 0,46 1,64 2,52 3,13 G04BE Midler mot erektil dysfunksjon G04BE01 Alprostadil (0,02 mg) G04BE03 Sildenafil (50 mg) G04BE04 Yohimbin (15 mg) 1) G04BE08 Tadalafil (10 mg) G04BE09 Vardenafil (10 mg) G04BE30 Papaverin/fentolamin 1) G04C Midler mot benign prostatahyperplasi 2) 10,14 10,89 11,44 11,82 13,06 G04CA01 Alfuzosin (7,5 mg) 0,04 G04CA02 Tamsulosin (0,4 mg) 6,34 6,58 6,65 6,74 7,20 G04CA03 Terazosin (5 mg) 0,09 0,08 0,08 0,07 0,06 G04CA52 Tamsulosin og dutasterid (1 kapsel) 0,70 1,37 1,91 2,32 3,11 G04CA53 Tamsulosin og solifenacin (1 kapsel) 0,03 G04CB01 Finasterid (5 mg) 2,75 2,67 2,62 2,53 2,52 G04CB02 Dutasterid (0,5 mg) 0,23 0,19 0,17 0,15 0,13 1) Inkluderer også salg av preparater uten markedsføringstillatelse i Norge. 2) Doxazosin, se ATC kode C02CA04. Legemiddelstatistikk 2017:1 Folkehelseinstituttet 49
Natural estrogens estradiol estrone estriol
Estrogens Natural estrogens estradiol estrone estriol Nonsteroidal synthetic Diethylstilbestrol Chlorotrianisene Methallenestril Steroidal synthetic Ethinyl estradiol Mestranol Quinestrol To decrease some
Dr Tarza Jamal Pharmacology Lecture 2
Contraceptives and androgen hormone Contraceptives: Currently, interference with ovulation is the most common pharmacologic intervention for preventing pregnancy. Major classes of contraceptives 1. Combination
Gonadal Hormones & Inhibitors
Gonadal Hormones & Inhibitors Estrogens Natural estrogens estradiol estrone estriol Nonsteroidal synthetic Diethylstilbestrol Chlorotrianisene Methallenestril Steroidal synthetic Ethinyl estradiol Mestranol
Estrogens & androgens ا.م.د.اسامة ايوب lec:4-6
Estrogens & androgens ا.م.د.اسامة ايوب lec:4-6 Sex hormones produced by the gonads are necessary for conception embryonic maturation, and development of primary and secondary sexual characteristics at
Monitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc.
Mr Mark Newman Monitoring Hormone Therapy Mark Newman, M.S. President of Precision Analytical Inc. 2 Avoiding Pitfalls in (B)HRT Monitoring and Picking the Right Lab Test Objectives: Outline how expected
Quarterly pharmacy formulary change notice
Provider Bulletin December 2017 Quarterly pharmacy formulary notice The formulary s listed in the table below apply to all Anthem HealthKeepers Plus members. These s were reviewed and approved at the third
Understanding combined oral contraception
Understanding combined oral contraception Paula Briggs, FFSRH Consultant in Community Sexual and Reproductive Health Southport and Ormskirk NHS Hospital Trust May Logan Centre, Bootle, L20 5DQ paulaeb@aol.com
Pupil: Learning target: Can receive a ball from a partner. Oaktree School Assessment. P4d up to 3. P4b up to 6. P4e up to 2. P4c up to 4.
P4 Can receive a ball from a partner Can throw a ball with prompts Can kick a ball with prompts Can perform single actions with prompts Responds to simple commands e.g. stop, go Identify specific pieces
Androgenes and Antiandrogenes
Androgenes and Antiandrogenes Androgens The androgens are a group of steroids that have anabolic and/or masculinizing effects in both males and females. Testosterone [tess-toss-terone], the most important
TRT and LUTS. Mick Jagger, 70 years. PRISM IV Sept 2014
TRT and LUTS Mick Jagger, 70 years PRISM IV Sept 2014 Combination of LUTS and LOH In ageing male : -LUTS increases -LOH increases So: the combination is a common clinical scenario TRT and LUTS Startingpoint
MALE HORMONE THERAPY OPTIONS
MALE HORMONE THERAPY OPTIONS The following tables have been compiled by Women s staff pharmacists to represent some of the more frequently prescribed regimens for men. The Women s logo is placed throughout
Safety and Tolerability of the Dual 5a-Reductase Inhibitor Dutasteride in thetreatment of Benign Prostatic Hyperplasia
European Urology European Urology 44 (2003) 82 88 Safety and Tolerability of the Dual 5a-Reductase Inhibitor in thetreatment of Benign Prostatic Hyperplasia Gerald L. Andriole a,*,1, Roger Kirby b a Division
Updates on Anti-doping and TUE Management in Paralympic Sport
International Paralympic Committee Updates on Anti-doping and TUE Management in Paralympic Sport Matthew Fedoruk, Ph.D. March 15, 2018 PyeongChang 2018 IPC Medical / Sports Science Committee Workshops
MALE HORMONE THERAPY OPTIONS
MALE HORMONE THERAPY OPTIONS The following tables have been compiled by Women s International Pharmacy staff pharmacists to represent some of the more frequently prescribed regimens for men. The Women
DUPROST Capsules (Dutasteride)
Published on: 10 Jul 2014 DUPROST Capsules (Dutasteride) Composition Each soft gelatin capsule contains: Dutasteride... 0.5 mg Dosage Form Capsule Pharmacology Pharmacodynamics Mechanism of Action Dutasteride
FINASTERIDE PER ALOPECIA ANDROGENETICA FEMMINILE
FINASTERIDE PER ALOPECIA ANDROGENETICA FEMMINILE ### 1 finasteride and depression Should finasteride be taken in am or pm, finasteride 5mg tab bald blog post ideas efectos. 2 Finasteride testosterone replacement
Clinical impact of type I and type II 5 alpha-reductase inhibition in prostatic disease: review and update 아주대학교김선일
Clinical impact of type I and type II 5 alpha-reductase inhibition in prostatic disease: review and update 아주대학교김선일 Development of 5ARI Discovery of 5AR type I and type II Pharmacodynamic and pharmacokinetic
Update on the use of dutasteride in the management of benign prostatic hypertrophy
REVIEW Update on the use of dutasteride in the management of benign prostatic hypertrophy Joe Miller Thomas Tarter Division of Urology, Southern Illinois University School of Medicine, Springfield, IL,
FINCAR Tablets (Finasteride)
Published on: 10 Jul 2014 FINCAR Tablets (Finasteride) Composition FINCAR Tablets Each film-coated tablet contains: Finasteride USP - 5 mg Dosage Form Tablet Pharmacology Pharmacodynamics Mechanism of
Inappropriate Testosterone Billings
Inappropriate Testosterone Billings Carla Patrick-Fagan March 30, 2015 Truven Health Analytics Inc. All Rights Reserved. 1 Agenda Proposed in the 2015 analytic plan Steroid prescriptions Code of Federal
Postmenopausal Hormone Therapy
PL Detail-Document #280506 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER May 2012 Postmenopausal Hormone
Elements for a public summary
VI.2 VI.2.1 Elements for a public summary Overview of disease epidemiology Prostate gland enlargement is a common condition as men get older. Also called benign prostatic hyperplasia (BPH) and prostatic
New Zealand Data Sheet
New Zealand Data Sheet 1. PRODUCT NAME TEROD 500 micrograms soft gelatin capsules. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 500 micrograms of dutasteride. For the full list of
Dutasteride Avodart Softgel Capsule
Dutasteride Avodart Softgel Capsule PRODUCT DESCRIPTION Dutasteride (Avodart ) is available as dull yellow, opaque, oblong soft gelatin capsules containing a clear, colourless to slightly yellow liquid.
WHY THE USE OF EITHER 5ALPHA REDUCTASE (5AR) INHIBITORS DUTASTERIDE/AVODART (MY CHOICE) OR FINASTERIDE/PROSCAR IN ANDROGEN DEPRIVATION THERAPY?
WHY THE USE OF EITHER 5ALPHA REDUCTASE (5AR) INHIBITORS DUTASTERIDE/AVODART (MY CHOICE) OR FINASTERIDE/PROSCAR IN ANDROGEN DEPRIVATION THERAPY? by Charles (Chuck) Maack, Prostate Cancer Activist/Mentor
Acyclovir Ointment. Aetna Better Health New Jersey. Products Affected. acyclovir ointment 5 % external Details. Criteria
Acyclovir Ointment acyclovir ointment 5 % external Aetna Better Health New Jersey Use of oral acyclovir or Abreva in the previous 130 days 1 Adcirca tadalafil (pah) tablet 20 mg oral Use of sildenafil
Mens Health Post Puberty. Nayan Patel PharmD
Mens Health Post Puberty Nayan Patel PharmD Definition of Androgen Deficiency * Consistently low testosterone * Associated signs/symptoms * Evidence based review of literature * Data is weak at best Definition
3. PHARMACEUTICAL FORM Capsules: dull yellow in colour, opaque, oblong soft gelatin capsules with GX CE2 printed on one side in red ink.
Avodart TM Dutasteride 1. NAME OF THE MEDICINAL PRODUCT AVODART* 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule for oral use contains 0.5 mg dutasteride. For excipients, see 6.1 List of Excepient.
Female testosterone level chart
Female testosterone level chart The Borg System is 100 % Female testosterone level chart Mar 23, 2015. Male, Female. Age: T Level (ng/dl):, Age: T Level (ng/dl):. 0-5 mo. 75-400, 0-5 mo. 20-80. 6 mos.-9
Sue Marty, Ph.D., D.A.B.T. The Dow Chemical Company TERA Endocrine Workshop April 23, 2013
Sue Marty, Ph.D., D.A.B.T. The Dow Chemical Company TERA Endocrine Workshop April 23, 2013 Agenda Value of WoE/MoA determinations in EDSP Information used to examine potential endocrine activity and/or
Icd 10 hormone replacement therapy male
Icd 10 hormone replacement therapy male 2018 ICD - 10 code for Hormone replacement therapy is Z79.890. Lookup the complete ICD 10 Code details for Z79.890. The ICD - 10 system requires that. TEENren who
FULL PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride)
Physician Copy. Patient: SAMPLE PATIENT DOB: Sex: MRN: ACH24.1
Physician Copy Patient: SAMPLE PATIENT DOB: Sex: MRN: ACH24.1 ID: Steroidogenic Pathway At-A-Glance 0.60 1 0.10 RR : 0-0.90 RR : 0.30-4.20 RR : 0.60-2.50 0.10 RR : 0.16-0.65 1.48 RR : 1.20-6.10 2.47 RR
STUDY OF THE EFFECT OF AN EXTRACT OF Serenoa repens on the production of the 5-α reductasa enzyme
STUDY OF THE EFFECT OF AN EXTRACT OF Serenoa repens on the production of the 5-α reductasa enzyme 1) ROLE OF 5-α-ALFA-REDUCTASA 5-α reductasas (5-α-R) are a family of enzymes involved in steroid metabolism.
Issues. What is a low testosterone? Who needs testosterone therapy? Benefits/adverse effects of testosterone replacement Treatment options
Male Hypogonadism Jauch Symposium Waterloo, IA May 17, 2013 Janet A. Schlechte, M.D. Disclosure of Financial Relationships Janet A. Schlechte, M.D. has no relationships with any proprietary entity producing
Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
대한남성과학회지 : 제 30 권제 1 호 2012 년 4 월 Korean J Androl. Vol. 30, No. 1, April 2012 http://dx.doi.org/10.5534/kja.2012.30.1.45 Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase
Clinical Significance of 5 -Reductase Activity
Clinical Significance of 5 -Reductase Activity By Jonathan Wright, MD and Barry Wheeler, ND 5 -Reductase (5AR) is the enzyme that catalyzes the conversion of (among others): Testosterone 5 -DHT Androstenedione
Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone
Natural Hair Transplant Medical Center, Inc. 1000 Dove Street, Suite #250, Newport Beach, CA 92660 Phone-949-622-6969 Finasteride (PROPECIA ) Acknowledgement Finasteride is an oral medication, manufactured
PRODUCT INFORMATION CF 3
PRODUCT INFORMATION AVODART SOFT CAPSULES NAME OF MEDICINE Dutasteride The chemical structure is: CH 3 O H N CF 3 CH 3 H O N H H H H CF 3 CAS Registry Number 164656-23-9. DESCRIPTION The chemical name
NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 1 mg of finasteride.
1. PRODUCT NAME Profal, film coated tablets, 1 mg NEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 1 mg of finasteride. Excipient of known effect: Lactose
PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor
PHYSICIANS CIRCULAR FINASTERIDE PROSCAR Tablet 5-Alpha Reductase Inhibitor FINASTERIDE (PROSCAR) a synthetic 4-azasteroid compound, is a specific inhibitor of Type II 5α-reductase, an intracellular enzyme
The Relevance of the Pharmacologic Properties of a Progestational Agent to Its Clinical Effects as a Combination Oral Contraceptive
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 62 (1989), 445-457 The Relevance of the Pharmacologic Properties of a Progestational Agent to Its Clinical Effects as a Combination Oral Contraceptive G. VIRGINIA
Clinical Policy: Testosterone Reference Number: AZ.CP.PHAR.02 Effective Date: Last Review Date: Line of Business: Arizona Medicaid
Clinical Policy: Reference Number: AZ.CP.PHAR.02 Effective Date: 11.16.16 Last Review Date: 09.12.18 Line of Business: Arizona Medicaid Revision Log See Important Reminder at the end of this policy for
DOSAGE FORMS AND STRENGTHS
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use finasteride tablets USP safely and effectively. See full prescribing information for finasteride
european urology 55 (2009)
european urology 55 (2009) 461 471 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia The Influence of Baseline Parameters on Changes in International
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective date: April 1, 2018 This policy has been developed through
The physiology of normal androgen production in
Mayo Clin Proc, April 2004, Vol 79 (Supplement) Formulations and Use of Androgens S3 Supplement Article Formulations and Use of Androgens in Women MICHELINE C. CHU, MD, AND ROGERIO A. LOBO, MD The physiology
ATRIO Health Plans 2018 SNP Plans Formulary Change Notice
Formulary ID: 18007 ATRIO Special Needs Plan ATRIO Special Needs Plan (Rogue) ATRIO Special Needs Plan (Willamette) ATRIO Health Plans 2018 SNP Plans Formulary Change Notice ATRIO Health Plans may remove
DUTASTERIDE capsules, for oral use Initial U.S. Approval: 2001
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Dutasteride capsules safely and effectively. See full prescribing information for Dutasteride capsules.
Associate Professor Geoff Braatvedt
Associate Professor Geoff Braatvedt Endocrinologist Diabetologist and Physician Green Lane and Auckland City Hospitals Auckland 14:00-14:55 WS #145: Approach to Low Testosterone Values 15:05-16:00 WS #157:
Although women produce only
For mass reproduction, content licensing and permissions contact Dowden Health Media. Mary Lake Polan, MD, PhD, MPH Katharine Dexter McCormick and Stanley McCormick Memorial Professor and Chair Emeritus,
Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University
Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University Objectives Introduce governing bodies in sport Review banned and restricted substances Discuss therapeutic
Danazol apollo
Danazol apollo +9191 46 950 950 Danazol apollo +9191 46 950 950 Danazol CAS Number : 17230-88-5 Molecular Weight : 337.46 g/mol Molecular Formula : C22H27NO2 Systematic (IUPAC) : (1S,2R,13R,14S,17R,18S)-17-
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent
Androgens and Anabolic Steroids Prior Authorization with Quantity Limit - Through Preferred Topical Androgen Agent Androgens/Anabolic Steroids Prior Authorization with Quantity Limit Through Preferred
EUROPEAN UROLOGY 57 (2010)
EUROPEAN UROLOGY 57 (2010) 123 131 available at www.sciencedirect.com journal homepage: www.europeanurology.com Benign Prostatic Hyperplasia The Effects of Combination Therapy with Dutasteride and Tamsulosin
Pros and Cons of Hormone Testing in Different Body Fluids with Different Routes of Hormone Delivery
Pros and Cons of Hormone Testing in Different Body Fluids with Different Routes of Hormone Delivery David T Zava, PhD ZRT laboratory A Guide to Steroid Hormone Testing in Different Body Fluids Following
AVODART (dutasteride) Soft Gelatin Capsules
AVODART (dutasteride) Soft Gelatin Capsules PRESCRIBING INFORMATION DESCRIPTION AVODART (dutasteride) is a synthetic 4-azasteroid compound that is a selective inhibitor of both the type 1 and type 2 isoforms
Drug Class Monograph
Drug Class Monograph Class: Testosterone Hormone Replacement Drug: Androderm (testosterone transdermal system), Androgel (testosterone topical gel), Axiron (testosterone topical solution), Aveed (testosterone
AVODART (dutasteride) Soft Gelatin Capsules
PRESCRIBING INFORMATION AVODART (dutasteride) Soft Gelatin Capsules DESCRIPTION AVODART (dutasteride) is a synthetic 4-azasteroid compound that is a selective inhibitor of both the type 1 and type 2 isoforms
Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride
Report Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride Jae Yoon Jung 1, MD, Je Ho Yeon 1, MD, Jee Woong Choi 1, MD, Soon Hyo Kwon 1, MD, Beom Joon Kim 2, MD,
PRODUCT INFORMATION CF 3
PRODUCT INFORMATION AVODART SOFT CAPSULES NAME OF MEDICINE Dutasteride The chemical structure is: CH 3 O H N CF 3 CH 3 H O N H H H H CF 3 CAS Registry Number 164656-23-9. DESCRIPTION The chemical name
FEMALE HORMONE THERAPY OPTIONS
FEMALE HORMONE THERAPY OPTIONS The following tables have been compiled by Women s International Pharmacy staff pharmacists to represent some of the more frequently prescribed regimens for women in menopause
ATRIO Health Plans 2018 PPO Plans Formulary Change Notice
Formulary ID: 18032 ATRIO Bronze Rx (Basin) ATRIO Silver Rx ATRIO Gold Rx ATRIO Bronze Rx (Umpqua) ATRIO Bronze Rx (Rogue) ATRIO Silver Rx (Rogue) ATRIO Gold Rx (Willamette) ATRIO Silver Rx (Willamette)
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
AVODART SOFT CAPSULES 0.5 MG 1. NAME OF THE MEDICINAL PRODUCT Avodart 0.5 mg capsules, soft. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 0.5 mg dutasteride. For excipients, see 6.1.
Testosterone Hormone Replacement Drug Class Prior Authorization Protocol
Line of business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Testosterone Hormone Replacement Drug Class Prior Authorization Protocol This policy has been developed through
Supplemental Table 1. Genotyping primers. Primer Sequence (5-3 ) Zfy. Sf1(Nr5a1)-Cre. Gata4. Gata6. Supplemental Table 2. Quantitative RT-PCR primers
Supplemental Table 1. Genotyping primers Zfy Sf1(Nr5a1)-Cre Gata4 Gata6 Primer Sequence (5-3 ) Forward: CTA-TTG-CAT-GGA-CAG-CAG-TCT-TAT-G Reverse: ACT-AGA-CAT-GTC-TTA-ACA-TCT-GTC-C Forward: GAG-TGA-ACG-AAC-CTG-GTC-GAA-ATC
CLINICAL ASSESSMENT AND DIAGNOSIS
FERTILITY AND STERILITY VOL. 77, NO. 4, SUPPL 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. CLINICAL ASSESSMENT
TREATMENT OPTIONS FOR MALE HYPOGONADISM
TREATMENT OPTIONS FOR MALE HYPOGONADISM Bruce Biundo, RPh, FACA PCCA Pharmacy Consulting Department Updated July 2012 Hypogonadism in men is primarily a state involving lower than expected levels of testosterone,
Product Monograph. Sandoz Dutasteride
Product Monograph Pr Sandoz Dutasteride Dutasteride Capsules of 0.5 mg Type I and II 5 Alpha-reductase Inhibitor Sandoz Canada Inc. 145 Jules-Léger Boucherville, QC, Canada J4B 7K8 Date of Preparation:
Epidemiology of hormonal contraceptivesrelated venous thromboembolism
Review J Hugon-Rodin and others Hormonal contraceptives and 171:6 R221 R230 MECHANISMS IN ENDOCRINOLOGY Epidemiology of hormonal contraceptivesrelated venous thromboembolism Justine Hugon-Rodin, Anne Gompel
Established in 1901 in Jerusalem by three young pharmacists selling drugs in a small store
Teva overview 2011 Established in 1901 in Jerusalem by three young pharmacists selling drugs in a small store More than 100 years later, we are among the top 15 pharmaceutical companies and the world leader
SILOFAST D Capsules (Silodosin + Dutasteride)
Published on: 26 Sep 2016 SILOFAST D Capsules ( + ) Composition SILOFAST D 4 Capsules Each combipack contains: 10 hard gelatin capsules of and 10 soft gelatin capsules of (A) hard gelatin capsules Each
Medical Policy An independent licensee of the Blue Cross Blue Shield Association
Androgens and Anabolic Steroids Page 1 of 57 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Androgens and Anabolic Steroids Prime Therapeutics will review Prior
WADA Technical Document TD2018MRPL
MINIMUM REQUIRED PERFORMANCE LEVELS FOR DETECTION AND IDENTIFICATION OF NON-THRESHOLD SUBSTANCES In order to ensure that all WADA-accredited Laboratories can report the presence of Prohibited Substances,
ARE FINASTERIDE SIDE EFFECTS PERMANENT
ARE FINASTERIDE SIDE EFFECTS PERMANENT Are Finasteride Side Effects Permanent Finasteride side effects in pregnant women Finasteride and dutasteride at the same time Does finasteride cause dizziness 1
Pharmacology 10 بسم هللا الرحمن ارحيم. Androgens and antiandrogens
بسم هللا الرحمن ارحيم Androgens and antiandrogens The androgens are a group of steroids that have anabolic and/or masculinizing effects in both males and females. Testosterone, the most important androgen
PROPECIA Tablets Merck Sharp & Dhome
PROPECIA Tablets Merck Sharp & Dhome 1. NAME OF THE MEDICINAL PRODUCT PROPECIA 1 mg Film-Coated Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet of Propecia contains 1 mg of finasteride
Testosterone Use and Effects
Parkland College Natural Sciences Poster Sessions Student Works 2013 Testosterone Use and Effects Brandon Mills Parkland College Recommended Citation Mills, Brandon, "Testosterone Use and Effects" (2013).
Complete. Male Hormones SAMPLE PATIENT. Patient: Order Number: Age: 47 Sex: M MRN:
Patient: Age: 47 Sex: M MRN: SAMPLE PATIENT Order Number: 81200334 Completed: September 20, 2007 Received: September 20, 2007 Collected: September 20, 2007 Complete Male Hormones Patient: SAMPLE PATIENT
Acyclovir Ointment. Aetna Better Health Kentucky. Products Affected. acyclovir ointment 5 % external Details. Criteria
Acyclovir Ointment acyclovir ointment 5 % external Aetna Better Health Kentucky Use of oral acyclovir or Abreva in the previous 130 days 1 Adcirca ADCIRCA TABLET 20 MG ORAL Use of sildenafil in previous
Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May Terry s Testosterone
Focus on CME at University of Alberta ADAM: Dealing with the Decline Donald W. Morrish, MD, PhD, FRCPC Presented at Mountain Man: Men's Health Conference, May 2005 We now know there is a decline in total
92:00. Miscellaneous Therapeutic Agents. 92:00 Miscellaneous Therapeutic Agents
Miscellaneous Therapeutic Agents Miscellaneous Therapeutic Agents ALENDRONATE SODIUM 70 MG ORAL TABLET 00002299712 00002352966 00002381494 00002248730 00002388553 00002385031 00002394871 00002286335 00002284006
HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES
Generic Brand HICL GCN Exception/Other METHYL ANDROID METHITEST METHYL TESTRED 01404 ROUTE MISCELL. CYPIONATE ENANTHATE GUIDELINES FOR USE ANDRODERM ANDROGEL AXIRON FORTESTA NATESTO STRIANT TESTIM VOGELXO
FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM
750 West Broadway Street Suite 905 Vancouver, BC M5Z 1K1 FAX: (604) 648-9003 vancouveroffice@donovanmedical.com FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM What is finasteride? Finasteride
Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended
Public Assessment Report for paediatric studies submitted in accordance with Article 45 of Regulation (EC) No1901/2006, as amended Andriol Testocaps, Sustanon and Testosterone Implants [] NL/W/0026/pdWS/001
Testosterone Effects in Transmen
Transmen Testosterone Effects in Transmen EFFECT Skin oiliness/acne Facial/body hair growth Scalp hair loss Increased muscle mass/strength Fat redistribution Cessation of menses Clitoral enlargement Vaginal
Pharmaceutical Chemistry
Pharmaceutical Chemistry Steroid Hormones and Therapeutically Related Compounds Assist. Prof. Karima fadhil Ali Al mustansiriyah university College of pharmacy Steroid Hormones and Therapeutically Related
FEMALE PATTERN HAIR LOSS
STUDY Finasteride Treatment of Female Pattern Hair Loss Matilde Iorizzo, MD; Colombina Vincenzi, MD; Stylianos Voudouris, MD; ianca Maria Piraccini, MD, PhD; Antonella Tosti, MD Objective: To evaluate
PROPECIA (Finasteride) Tablets, 1 mg
9328502 PROPECIA (Finasteride) Tablets, 1 mg DESCRIPTION PROPECIA * (finasteride), a synthetic 4-azasteroid compound, is a specific inhibitor of steroid Type II 5α-reductase, an intracellular enzyme that
Norethindrone acetate vs desogestrel
Norethindrone acetate vs desogestrel 04/28/2018 Ess self service northwell health 04/30/2018 Red hi tech codeine syrup 05/02/2018 -Teenrens benadryl dosage for babies -Average dose of tramadol 05/02/2018
Efficacy and Safety of Long-TermTreatment with the Dual 5a-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia
European Urology European Urology 46 (2004) 488 495 Efficacy and Safety of Long-TermTreatment with the Dual 5a-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic Hyperplasia Frans
2011 PROHIBITED DRUG CLASSES AND METHODS. Dr Nicolas Theron Loch Logan Waterfront Sport and Travel Medicine Centre Tel :
2011 PROHIBITED DRUG CLASSES AND METHODS Dr Nicolas Theron Loch Logan Waterfront Sport and Travel Medicine Centre Tel : 051-4481389 Doping is defined as the administration of substances belonging to prohibited
Summary. Introduction. Dow Stough, MD
Original Contribution Blackwell Publishing ORIGINAL Inc CONTRIBUTION Dutasteride improves male pattern hair loss in a randomized study in identical twins Dow Stough, MD The Dermatology Clinic, Hot Springs,
PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)
PRODUCT INFORMATION TESTOVIRON DEPOT (testosterone enanthate) NAME OF THE MEDICINE Testosterone enanthate is designated chemically as 17 beta-heptanoyloxy-4-androstene-3- one. The empirical formula of
TESTOFEN. Anabolic & Androgenic Activity GENCOR PACIFIC, INC. Fenugreek Extract standardized for FENUSIDE TM. Copyright 2005 by Gencor Pacific, Inc.
GENCOR PACIFIC, INC. 920E. Orangethorpe Avenue, Suite B, Anaheim, CA. 92801 Ph: 714.870.8723 714.870.8724 efax: 732.875.0306 drjit@gencorpacific.com manu@gencorpacific.com www.gencorpacific.com TESTOFEN
Scrum Agile Software Development
http://home.hit.no/~hansha/?page=software_development Scrum Agile Software Development S. Adams. Dilbert. Available: http://dilbert.com Hans-Petter Halvorsen Typical Job Ad Agile methods and especially
1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride
1001 West Broadway, Vancouver, BC V6H 4B1 Topical Finasteride 1 Topical finasteride is a solution containing the drug finasteride typically sold under the brand names Propecia and Proscar. The Finasteride
SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Finasterid Actavis 5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 5 mg finasteride.
SUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Finpros 5 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 5 mg finasteride. Excipient
Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
World J Urol (2010) 28:9 15 DOI 10.1007/s00345-009-0493-y TOPIC PAPER Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH Stavros Gravas Matthias Oelke Received: